Cambridge, MA and Shenzhen, China – On April 27, BGI hosted a festive celebration in Boston, Massachusetts to commemorate the one-year anniversary of BGI Americas and express appreciation to BGI’s valued collaborators, friends and associates. Held at the Hampshire House, a turn-of-the-century mansion on historic Beacon Hill, the anniversary celebration was attended by approximately 100 guests from Merck & Co., Eli Lilly, Pfizer, Novartis, Sanofi-Aventis, Biogen-Idec, Astrazeneca, New England Biolabs, Harvard Medical School, MIT, Dana-Farber Cancer Institute, NYU Langone Medical Center, Boston University, University of California-Davis, University of Ottawa, Children’s Hospital of Philadelphia, etc.
Prof. Huanming Yang, Co-founder and Chairman of BGI, welcomed the guests with a toast expressing appreciation to friends and supporters who have contributed to the success of BGI and BGI Americas. Prof. Yang also gave a presentation highlighting BGI’s history, progress and future vision. Dr. Greg Wang, Executive Vice President of BGI Americas also offered welcoming remarks.
Other key representatives of BGI Americas included Yuqing Jiang, Chief Operating Officer; Don Benson, Senior Director of Sales, Eastern Region; Dr. Nong Chen, Director of Sales; Xu Zhang, Senior Director or Operations; Dr. Lili Niu, Applications Science Manager; Dr. Bicheng Yang, Global Marketing Director, BGI; and Dr. Joyce Peng, Marketing Director of BGI Americas, who served as master of ceremonies for the event.
The evening’s entertainment included an artful sand painting created by Mr. Dabao Su and narrated by Jenny Weng of BGI Americas, depicting the evolution of genomics and BGI’s history contributions. An uplifting video presented provided a present-day look at BGI, its facilities, employees and ongoing scientific activities.
BGI (formerly known as Beijing Genomics Institute) was founded in 1999 and has since become the largest genomic organization in the world. With a focus on research and applications in the healthcare, agriculture, conservation and bio-energy fields, BGI has a proven track record of innovative, high-profile research which has generated over 178 publications in top-tier journals such as Nature and Science. BGI’s distinguished achievements have made a great contribution to the development of genomics in both China and the world. Our goal is to make leading-edge genomics highly accessible to the global research community by leveraging industry’s best technology, economies of scale and expert bioinformatics resources. BGI and its affiliates, BGI Americas and BGI Europe, have established partnerships and collaborations with leading academic and government research institutions, as well as global biotechnology and pharmaceutical companies. At BGI, we have built the infrastructure and scientific expertise to enable our customers and collaborators to quickly migrate from samples to discovery.
For more information, visit www.bgisequence.com.
For additional information:
Bicheng Yang, Ph.D.
Global Marketing Director
Joyce Peng, Ph.D.
BGI Americas Corporation